DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 2005
Publisher
MDPI AG
Online
2018-07-09
DOI
10.3390/ijms19072005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells
- (2018) Kohei Taniguchi et al. MOLECULAR CARCINOGENESIS
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DDX6 Orchestrates Mammalian Progenitor Function through the mRNA Degradation and Translation Pathways
- (2015) Ying Wang et al. MOLECULAR CELL
- Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells
- (2014) Nami Yamada et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
- (2014) Cecília Durães et al. VIRCHOWS ARCHIV
- Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo
- (2013) Shunsuke Noguchi et al. MOLECULAR THERAPY
- Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
- (2012) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction
- (2012) B. E. Phillips et al. DISEASES OF THE ESOPHAGUS
- Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells
- (2012) Ryutaro Mori et al. Gastric Cancer
- Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
- (2012) Fei Zhou et al. World Journal of Surgical Oncology
- Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma
- (2011) Shi-Yan Yan WORLD JOURNAL OF GASTROENTEROLOGY
- Low frequency of HER2 amplification and overexpression in early onset gastric cancer
- (2011) Cathy B. Moelans et al. CELLULAR ONCOLOGY
- Role of anti-oncomirs miR-143 and -145 in human colorectal tumors
- (2010) Y Akao et al. CANCER GENE THERAPY
- Trastuzumab in gastric cancer
- (2010) Alicia F.C. Okines et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- HER-2 amplification is highly homogenous in gastric cancer
- (2009) Michael Bilous et al. HUMAN PATHOLOGY
- FGFR2-related pathogenesis and FGFR2-targeted therapeutics (Review)
- (2009) Katoh INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
- (2008) Henrike E. Karim-Kos et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started